Quick Answer
INTERPACE BIOSCIENCES, INC. reported Cash And Cash Equivalents At Carrying Value of $2.51 million for the year ending 2025.
- INTERPACE BIOSCIENCES, INC. showed an increase of +71.5% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from INTERPACE BIOSCIENCES, INC.'s annual report (Form 10-K), filed with the SEC on March 30, 2026.
- XBRL data for this metric is available from 2009 to 2025 (22 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 22 years of available data (2009 to 2025), INTERPACE BIOSCIENCES, INC.'s Cash And Cash Equivalents At Carrying Value has declined by 96.5%.
- Historical annual values: Fiscal year 2025: $2.51 million | Fiscal year 2024: $1.46 million | Fiscal year 2024: $2.11 million | Fiscal year 2024: $2.02 million | Fiscal year 2024: $2.81 million | Fiscal year 2023: $3.50 million | Fiscal year 2023: $5.08 million | Fiscal year 2023: $5.60 million | Fiscal year 2022: $4.83 million | Fiscal year 2021: $2.67 million | Fiscal year 2020: $2.77 million | Fiscal year 2019: $2.32 million | Fiscal year 2018: $6.07 million | Fiscal year 2017: $15.20 million | Fiscal year 2016: $602.0 thousand | Fiscal year 2015: $8.31 million | Fiscal year 2014: $23.11 million | Fiscal year 2013: $45.64 million | Fiscal year 2012: $52.78 million | Fiscal year 2011: $64.34 million | Fiscal year 2010: $62.71 million | Fiscal year 2009: $72.46 million.
- Data sourced from SEC EDGAR public filings as of June 24, 2026.
Last verified: